Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
RDW Prognostic Marker in HF and Predictor for Iron Replacement Responsivene
Author(s): Artemio García-Escobar , Rosa Lázaro-García , Javier Goicolea-Ruigómez , et al Added: 1 year ago

Heart Failure
EPCs and Innovative Strategies for Endothelial Dysfunction in Heart Failure
Author(s): Eugenio Carulli , Marialuisa Sveva Marozzi , Maria Cristina Carella , et al Added: 10 months ago

Prevention & Chronic Conditions

Heart Failure
ACC 2025: The CardiAMP-HF Trial
Author(s): Amish Raval Added: 1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more

Heart Failure
THT 2025: GSN Ablation in HFpEF
Author(s): Marat Fudim Added: 1 year ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat… View more

Heart Failure
Time in Target Ambulatory Blood Pressure Range Linked to Lower CV Risk
Added: 10 months ago Source:  Radcliffe Cardiology
A new meta-analysis suggests that the more time an individual's ambulatory blood pressure (ABP) is within the target range proposed by the 2024 European Society of Cardiology (ESC) guidelines, the lower their risk of mortality and cardiovascular events.¹ The findings also highlight that office blood pressure measurements frequently misclassify patients with regard to their actual blood pressure… View more

Prevention & Chronic Conditions

Demographic
Added: 11 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Job title: Specialist in General Surgery and Emergency Surgery, a Researcher in Cardiovascular Medicine and Director of Cardiovascular Research Laboratory of the Cardiac, Thoracic and Vascular Department
Heather Landau
Job title: Associate Attending Physician
Dr Heather J. Landau, MD, is an Associate Attending Physician on the Adult Bone Marrow Transplant, Cellular Therapy, and Multiple Myeloma services at Memorial Sloan Kettering (MSK) Cancer Center. She is the Director of the Amyloidosis Program, where she leads a multidisciplinary group focused on clinical and translational research to improve outcomes for patients with AL amyloidosis.Dr Landau has… View more
Job title: Medical Scientist, Department of Gene and Cell Research
Jeffrey L Carson
Dr Jeffrey Carson, currently serving as the Provost, New Brunswick at Rutgers Biomedical and Health Sciences, brings a wealth of experience and leadership to the field of medicine. Formerly the Chief of the Division of General Internal Medicine until 2015, he holds the esteemed position of Distinguished Professor of Medicine and occupies the Richard C. Reynolds, M.D. Chair in General Internal… View more